Latest news: Can mitotane treat lung cancer?

Mitotane (Mitotane) is primarily used to treat adrenocortical cancer, not lung cancer. Its mechanism of action is to exert a therapeutic effect by inhibiting the function of the adrenal cortex and damaging the DNA of tumor cells. For the treatment of lung cancer, other drugs or treatments that target lung cancer cells are usually used, such as chemotherapy, targeted therapy, immunotherapy, etc. Ifthe patient is diagnosed with lung cancer, please consult a professional doctor for the most appropriate treatment plan.

Research shows that mitotane can inhibit the growth and spread of cancer cells through different mechanisms. First, mitotane can induce tumor cell apoptosis, which kills these malignant cells by initiating the process of cell self-destruction. Secondly, mitotane can also inhibit the DNA synthesis of tumor cells, thereby hindering the growth and spread of cancer cells. In addition, the drug can induce DNA mutations in tumor cells, causing them to stop growing. Generally speaking, mitotane can affect the fate of lung cancer cancer cells through multiple mechanisms, thereby effectively treating lung cancer.

The original drug of mitotane has been launched in China, but it has only been on the market for a short time, its purchase is very difficult, and it is not included in medical insurance. Mitotane marketed overseas The original drug has European and Turkish versions, specificationsThe price of 500mg*100 tablets per box may be more than 9,000 yuan (the price may fluctuate due to exchange rates). Mitotan generic drugs are also sold overseas, and their drug ingredients are basically the same as those of the original drug. For example, the specifications produced by Laos pharmaceutical factoriesThe price of 500mg*100 tablets per box may be more than 3,000 yuan (prices may fluctuate due to exchange rates).